JM
J.P. Morgan analysts
Executive
J.P. Morgan analysts provide financial insights and analysis.
Notable Quotes
"the trial miss was a significant setback that could curb demand for CagriSema, temper long-term sales hopes and leave Novo struggling to win back share in the fast-growing obesity treatment market."View Story →